151
Views
85
CrossRef citations to date
0
Altmetric
Original Research

In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy

, , , &
Pages 1251-1258 | Published online: 06 Mar 2012

References

  • MaedaHFangJInutsukaTKitamotoYVascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implicationsInt Immunopharmacol20033331932812639809
  • GoodrichGBaoLGill-SharpKSangKWangJPayneJDPhotothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorodsJ Biomed Opt201015101800120210487
  • LooCLoweryAHalasNWestJCrezekRImmunotargeted nanoshells for integrated cancer imaging and therapyNano Lett20055470971115826113
  • SokolovKFollenMAaronJReal-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticlesCancer Res20036391999200412727808
  • LooCHirschLLeeMHGold nanoshell bioconjugates for molecular imaging in living cellsOpt Lett20053091012101415906987
  • ChoiCHAlabiCAWebsterPDavisMEMechanism of active targeting in solid tumors with transferrin-containing gold nanoparticlesProc Natl Acad Sci U S A201010731235124020080552
  • WilliamsKJTelferBAStratfordIJWedgeSRZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft modelBr J Cancer20028671157116111953865
  • KatoTSatoKKakinumaHMatsudaYEnhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in miceCancer Res19945419514351477522956
  • SantiniDVincenziBLa CesaAA new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot studyAnticancer Res2005251B66967415816644
  • SchluepTHwangJChengJPreclinical efficacy of the camptothecin- polymer conjugate IT-101 in multiple cancer modelsClin Cancer Res20061251606161416533788
  • HerbstRSMaddoxAMRothenburgMLSelective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trialJ Clin Oncol200220183815382512228201
  • HirschLRStaffordRJBanksonJANanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidanceProc Natl Acad Sci U S A200310023135491355414597719
  • HuangXEl-SayedIHQianWEl-SayedMACancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorodsJ Am Chem Soc200612862115212016464114
  • De JongWHHagensWIKrystekPBurgerMCSipsAJGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
  • TerentyukGSMaslyakovaGNSuleymanoveLVCirculation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle deliveryJ Biophotonics20092529230219434616
  • MelanconMPLuWYangZIn vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapyMol Cancer Ther2008761730173918566244
  • WangJByrneJDNapierMEDeSimoneJMMore effective nano-medicines through particle designSmall20117141919193121695781
  • NomuraTKoreedaNYamashitaFTakakuraYHashidaMEffect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumorsPharm Res19981511281329487559
  • Hu-LieskovanSHeidelJDBartlettDWDavisMETricheTJSequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcomaCancer Res200565198984899216204072
  • DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
  • PerraultSDWalkeyCJenningsTFischerHCChanWCMediating tumor targeting efficiency of nanoparticles through designNano Lett2009951909191519344179
  • OldenburgSJAverittRDWestcottSLHalasNJNanoengineering of optical resonancesChem Phys Letters1998288243247
  • JanaNRGeargartLMurphyCJWet chemical synthesis of high aspect ratio cylindrical gold nanorodsJ Physl Chem B20011051940654067
  • JamesWDHirschLRWestJLO’NealPDPayneJDApplication of INAA to the build-up and clearance of gold nanoshells in clinical studies in miceJ Radio Nucl Chem2007271455459
  • BartlettDWDavisMEImpact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticlesBiotechnol Bioeng200899497598517929316
  • O’NealDPHirschLRHalasNJPayneJDWestJLPhoto-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Lett2004209217117615159019
  • PuvanakrishnanPDiagaradjanePKazmiSMDunnAKKrishnanSTunnellJWNarrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorodsLasers Surg Med
  • ParkJEstradaASchwartzJAIntra-organ biodistribution of gold nanoparticles using intrinsic two-photon induced photoluminescenceLasers Surg Med201042763063921399728
  • PuvanakrishnanPParkJDiagaradjanePNear-infrared narrow band imaging of gold/silica nanoshells in tumorsJ Biomed Opt200914202404419405772
  • JainRKTransport of molecules, particles, and cells in solid tumorsAnnu Rev Biomed Eng1999124126311701489
  • JainRkBaxterLTMechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressureCancer Res19884824 Pt 1702270323191477
  • BoucherYBaxterLTJainRKInterstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapyCancer Res19905015447844842369726
  • ChoiHSLiuWMisraPRenal clearance of quantum dotsNat Biotechnol200725101165117017891134
  • HobbsSKMonskyWLYuanRRegulation of transport pathways in tumor vessels: role of tumor type and microenvironmentProc Natl Acad Sci U S A1998958460746129539785